The discussion focused on the following axes: Government hospital dues, which Al-Abyad explained would be “paid within the next few weeks.” He also stressed “the need to pay the dues of workers in government hospitals and implement the item related to increasing their salaries contained in the General Budget Law.”
The meeting discussed the Ministry of Health’s efforts to secure cancer medicines for patients in these hospitals, and projects aimed at supporting and expanding cancer treatment departments. Noting that, soon, cancer treatment departments will be opened in four government hospitals.
They also discussed the Ministry’s efforts to accelerate the implementation of cooperation projects with donors such as the United Nations High Commissioner for Refugees (UNHCR) and some guarantors, which aim to improve the services provided in government hospitals and the workflow in them.
Al-Abyadh also held a meeting with the directors of private hospitals that have departments for the treatment of cancer diseases, and that adopt the Meditrack system, in order to find out regarding the progress of work in them and the challenges that cancer patients face in terms of securing medicine and the cost of treatment sessions.
The Minister of Health informed the managers of the agreement reached with the Importers Syndicate to give hospitals an additional period to pay the dues of the importers, explaining “the ministry’s efforts to expedite the process of paying the dues of private hospitals for the year 2023, especially following approving their contracts for this year early, which is happening for the first time in the history of the Ministry of Health.” Which would reflect positively on the citizen and relieve him of the trouble at the gates of hospitals.
The research also dealt with the preliminary results of applying the Meditrack tracking system and mechanizing drug distribution, which were positive, in terms of securing cancer patients’ access to their medicines included in this system, which has reached, so far, 55 medicines for cancerous and incurable diseases. Al-Abyadh stressed that “work on the Meditrack tracking system is continuing to include all types of medicines.”
